Association of vitamin B in schizophrenia
Autor(a) principal: | |
---|---|
Data de Publicação: | 2020 |
Outros Autores: | , , , |
Tipo de documento: | Artigo |
Idioma: | por |
Título da fonte: | Scire Salutis |
Texto Completo: | https://sustenere.inf.br/index.php/sciresalutis/article/view/CBPC2236-9600.2021.001.0009 |
Resumo: | Schizophrenia is a serious neuropsychiatric disorder that not only causes a great deal of disease, but also challenges our understanding of how the mind and brain work. Schizophrenia affects around 1% of the world population, just in Brazil more than 2 million people suffer from this disorder and according to the Brazilian Psychiatric Association, the disease is prevalent in males and is usually not diagnosed at the beginning. The diagnosis is based on a constellation of clinical symptoms and not on a common pathomechanism. Vitamins are organic compounds, needed in small amounts for normal metabolism and that cannot be manufactured by the cells of the body. Water-soluble substances are absorbed by the intestine and transported through the circulatory system to the tissues in which they will be used, they are not stored and are easily excreted by the kidneys, so they must be ingested daily, in this group are vitamins B. The B complex can be used as coenzymes in macronutrient catabolism to produce energy for the human body. Research shows that ancillary treatment with B vitamins at a high dose - including B6, B8 and B12 - can significantly reduce symptoms of treatments more than standard schizophrenia alone. A bibliographic search was made using the Google academic databases, Scielo, Pubmed and Lilacs, with schizophrenia, B complex, vitamin B and schizophrenia spectrum as descriptors. 21 articles were included that met the inclusion criteria. In conclusion, the administration of vitamins B6, B9 and B12 had positive results in relation to memory and negative symptoms of schizophrenic patients, it is also necessary to develop a new animal model, since the use of the current one for the study of schizophrenia has not yet it's efficient. |
id |
ESS-1_3d4988f4d21e4983e021c33e985ce602 |
---|---|
oai_identifier_str |
oai:ojs.pkp.sfu.ca:article/4889 |
network_acronym_str |
ESS-1 |
network_name_str |
Scire Salutis |
repository_id_str |
|
spelling |
Association of vitamin B in schizophreniaAssociação da vitamina B na esquizofreniaEsquizofreniaComplexo BVitamina BEspectro de EsquizofreniaSchizophreniaComplex BVitamin BSchizophrenia SpectrumSchizophrenia is a serious neuropsychiatric disorder that not only causes a great deal of disease, but also challenges our understanding of how the mind and brain work. Schizophrenia affects around 1% of the world population, just in Brazil more than 2 million people suffer from this disorder and according to the Brazilian Psychiatric Association, the disease is prevalent in males and is usually not diagnosed at the beginning. The diagnosis is based on a constellation of clinical symptoms and not on a common pathomechanism. Vitamins are organic compounds, needed in small amounts for normal metabolism and that cannot be manufactured by the cells of the body. Water-soluble substances are absorbed by the intestine and transported through the circulatory system to the tissues in which they will be used, they are not stored and are easily excreted by the kidneys, so they must be ingested daily, in this group are vitamins B. The B complex can be used as coenzymes in macronutrient catabolism to produce energy for the human body. Research shows that ancillary treatment with B vitamins at a high dose - including B6, B8 and B12 - can significantly reduce symptoms of treatments more than standard schizophrenia alone. A bibliographic search was made using the Google academic databases, Scielo, Pubmed and Lilacs, with schizophrenia, B complex, vitamin B and schizophrenia spectrum as descriptors. 21 articles were included that met the inclusion criteria. In conclusion, the administration of vitamins B6, B9 and B12 had positive results in relation to memory and negative symptoms of schizophrenic patients, it is also necessary to develop a new animal model, since the use of the current one for the study of schizophrenia has not yet it's efficient.A esquizofrenia é um distúrbio neuropsiquiátrico grave que não só causa uma grande carga de doenças, mas também desafia nossa compreensão de como a mente e o cérebro funcionam. A esquizofrenia afeta em torno de 1% da população mundial, somente no Brasil mais de 2 milhões de pessoas sofrem com esse distúrbio e segundo a Associação Brasileira de Psiquiatria, a doença é predominante no sexo masculino e normalmente não é diagnosticada no início. O diagnóstico é baseado em uma constelação de sintomas clínicos e não em um pato mecanismo comum. A vitaminas são compostos orgânicos, necessários em pequenas quantidades para o metabolismo normal e que não podem ser fabricadas pelas células do corpo. As hidrossolúveis são absorvidas pelo intestino e transportadas pelo sistema circulatório até os tecidos em que serão utilizadas, não são armazenadas e são facilmente excretadas pelos rins, por isso devem ser ingeridas diariamente, neste grupo estão as vitaminas B. O complexo B pode ser usado como coenzimas no catabolismo de macronutrientes para produzir energia para o corpo humano. Pesquisas demonstram que tratamento auxiliar com vitaminas B com uma alta dose - incluindo B6, B8 e B12 - pode significativamente reduzir sintomas de tratamentos mais do que padrão da esquizofrenia apenas. Uma pesquisa bibliográfica foi feita utilizando as bases de dados Google acadêmico, Scielo, Pubmed e Lilacs, com esquizofrenia, complexo B, vitamina B e espectro de esquizofrenia como descritores. 21 artigos foram incluídos que atenderam os critérios de inclusão. Em conclusão, a administração de vitaminas B6, B9 E B12 tiveram resultados positivos em relação a memória e a sintomas negativos de pacientes esquizofrênicos, também é necessário o desenvolvimento de um novo modelo animal, pois a utilização do atual para o estudo da esquizofrenia ainda não é eficiente.Sustenere Publishing2020-09-21info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://sustenere.inf.br/index.php/sciresalutis/article/view/CBPC2236-9600.2021.001.000910.6008/CBPC2236-9600.2021.001.0009Scire Salutis; Vol. 11 No. 1 (2021): Scire Salutis - Out, Nov, Dez 2020, Jan 2021; 76-83Scire Salutis; Vol. 11 Núm. 1 (2021): Scire Salutis - Out, Nov, Dez 2020, Jan 2021; 76-83Scire Salutis; v. 11 n. 1 (2021): Scire Salutis - Out, Nov, Dez 2020, Jan 2021; 76-832236-9600reponame:Scire Salutisinstname:Companhia Brasileira de Produção Científica (CBPC)instacron:ESSporhttps://sustenere.inf.br/index.php/sciresalutis/article/view/CBPC2236-9600.2021.001.0009/2431Copyright (c) 2021 Scire Salutisinfo:eu-repo/semantics/openAccessSoares, Juliana VerasCapelo, Melissa FigueiredoSanford, Ana Beatriz AguiarMesquita, Dara da SilvaHonório Júnior, José Eduardo Ribeiro2023-01-04T20:17:15Zoai:ojs.pkp.sfu.ca:article/4889Revistahttps://sustenere.co/index.php/sciresalutisONGhttps://sustenere.co/index.php/sciresalutis/oai||carlos@arvore.org.br2236-96002236-9600opendoar:2023-01-04T20:17:15Scire Salutis - Companhia Brasileira de Produção Científica (CBPC)false |
dc.title.none.fl_str_mv |
Association of vitamin B in schizophrenia Associação da vitamina B na esquizofrenia |
title |
Association of vitamin B in schizophrenia |
spellingShingle |
Association of vitamin B in schizophrenia Soares, Juliana Veras Esquizofrenia Complexo B Vitamina B Espectro de Esquizofrenia Schizophrenia Complex B Vitamin B Schizophrenia Spectrum |
title_short |
Association of vitamin B in schizophrenia |
title_full |
Association of vitamin B in schizophrenia |
title_fullStr |
Association of vitamin B in schizophrenia |
title_full_unstemmed |
Association of vitamin B in schizophrenia |
title_sort |
Association of vitamin B in schizophrenia |
author |
Soares, Juliana Veras |
author_facet |
Soares, Juliana Veras Capelo, Melissa Figueiredo Sanford, Ana Beatriz Aguiar Mesquita, Dara da Silva Honório Júnior, José Eduardo Ribeiro |
author_role |
author |
author2 |
Capelo, Melissa Figueiredo Sanford, Ana Beatriz Aguiar Mesquita, Dara da Silva Honório Júnior, José Eduardo Ribeiro |
author2_role |
author author author author |
dc.contributor.author.fl_str_mv |
Soares, Juliana Veras Capelo, Melissa Figueiredo Sanford, Ana Beatriz Aguiar Mesquita, Dara da Silva Honório Júnior, José Eduardo Ribeiro |
dc.subject.por.fl_str_mv |
Esquizofrenia Complexo B Vitamina B Espectro de Esquizofrenia Schizophrenia Complex B Vitamin B Schizophrenia Spectrum |
topic |
Esquizofrenia Complexo B Vitamina B Espectro de Esquizofrenia Schizophrenia Complex B Vitamin B Schizophrenia Spectrum |
description |
Schizophrenia is a serious neuropsychiatric disorder that not only causes a great deal of disease, but also challenges our understanding of how the mind and brain work. Schizophrenia affects around 1% of the world population, just in Brazil more than 2 million people suffer from this disorder and according to the Brazilian Psychiatric Association, the disease is prevalent in males and is usually not diagnosed at the beginning. The diagnosis is based on a constellation of clinical symptoms and not on a common pathomechanism. Vitamins are organic compounds, needed in small amounts for normal metabolism and that cannot be manufactured by the cells of the body. Water-soluble substances are absorbed by the intestine and transported through the circulatory system to the tissues in which they will be used, they are not stored and are easily excreted by the kidneys, so they must be ingested daily, in this group are vitamins B. The B complex can be used as coenzymes in macronutrient catabolism to produce energy for the human body. Research shows that ancillary treatment with B vitamins at a high dose - including B6, B8 and B12 - can significantly reduce symptoms of treatments more than standard schizophrenia alone. A bibliographic search was made using the Google academic databases, Scielo, Pubmed and Lilacs, with schizophrenia, B complex, vitamin B and schizophrenia spectrum as descriptors. 21 articles were included that met the inclusion criteria. In conclusion, the administration of vitamins B6, B9 and B12 had positive results in relation to memory and negative symptoms of schizophrenic patients, it is also necessary to develop a new animal model, since the use of the current one for the study of schizophrenia has not yet it's efficient. |
publishDate |
2020 |
dc.date.none.fl_str_mv |
2020-09-21 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://sustenere.inf.br/index.php/sciresalutis/article/view/CBPC2236-9600.2021.001.0009 10.6008/CBPC2236-9600.2021.001.0009 |
url |
https://sustenere.inf.br/index.php/sciresalutis/article/view/CBPC2236-9600.2021.001.0009 |
identifier_str_mv |
10.6008/CBPC2236-9600.2021.001.0009 |
dc.language.iso.fl_str_mv |
por |
language |
por |
dc.relation.none.fl_str_mv |
https://sustenere.inf.br/index.php/sciresalutis/article/view/CBPC2236-9600.2021.001.0009/2431 |
dc.rights.driver.fl_str_mv |
Copyright (c) 2021 Scire Salutis info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
Copyright (c) 2021 Scire Salutis |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Sustenere Publishing |
publisher.none.fl_str_mv |
Sustenere Publishing |
dc.source.none.fl_str_mv |
Scire Salutis; Vol. 11 No. 1 (2021): Scire Salutis - Out, Nov, Dez 2020, Jan 2021; 76-83 Scire Salutis; Vol. 11 Núm. 1 (2021): Scire Salutis - Out, Nov, Dez 2020, Jan 2021; 76-83 Scire Salutis; v. 11 n. 1 (2021): Scire Salutis - Out, Nov, Dez 2020, Jan 2021; 76-83 2236-9600 reponame:Scire Salutis instname:Companhia Brasileira de Produção Científica (CBPC) instacron:ESS |
instname_str |
Companhia Brasileira de Produção Científica (CBPC) |
instacron_str |
ESS |
institution |
ESS |
reponame_str |
Scire Salutis |
collection |
Scire Salutis |
repository.name.fl_str_mv |
Scire Salutis - Companhia Brasileira de Produção Científica (CBPC) |
repository.mail.fl_str_mv |
||carlos@arvore.org.br |
_version_ |
1793890278257459200 |